Foreign-Trade Zone (FTZ) 76-Danbury, Connecticut Notification of Proposed Production Activity; MannKind Corporation, (Fumaryl Diketopiperazone (FDKP) Carrier/Receptor Powder), Danbury, Connecticut, 1689 [2016-32034]

Download as PDF Federal Register / Vol. 82, No. 4 / Friday, January 6, 2017 / Notices II. Basis for CAPS Expansion DEPARTMENT OF COMMERCE A. Purpose Foreign-Trade Zones Board CAPS is designed to provide managers at the lowest organizational level the authority, control, and flexibility to recruit, retain, develop, recognize, and motivate its workforce, while ensuring adequate accountability and oversight. The ESO is a new organization designed to deliver common business support and mission-enabling services in the functional areas of human resources, acquisition, information technology financial management, and other areas as determined necessary. The mission of the ESO is to: Enhance customer experience through the efficient delivery of high-quality mission-enabling services; increase service transparency and accountability; and enable employees, currently performing these functions, to dedicate more time to the unique mission needs of their organization. The expansion of CAPS coverage to include the ESO, should improve the organization’s ability to recruit and retain a highquality workforce to meet the organization’s mission. DoC’s CAPS allows for modifications of procedures if no new waiver from law or regulation is added. Given that this expansion and modification is in accordance with existing law and regulation and CAPS is a permanent alternative personnel system, the DoC is authorized to make the changes described in this notice. B. Participating Employees Employee notification of this expansion will be accomplished by providing employees and managers electronic access to all CAPS policies and procedures, including the eleven previous Federal Register Notices. A copy of this Federal Register notice will also be accessible electronically upon approval. Supervisor training and informational briefings for employees will be conducted as the ESO undergoes full transition over a period of a few years. sradovich on DSK3GMQ082PROD with NOTICES III. Changes to the Project Plan The CAPS at DoC, published in the Federal Register on December 24, 1997 (62 FR 67434), is amended as follows: 1. The following organization will be added to the project plan, Section II D— Participating Organizations Office of the Secretary (OS), Office of the Deputy Secretary, Enterprise Services Organization (ESO) [FR Doc. 2017–00057 Filed 1–5–17; 8:45 am] BILLING CODE 3510–EA–P VerDate Sep<11>2014 18:06 Jan 05, 2017 Jkt 241001 [B–085–2016] Foreign-Trade Zone (FTZ) 76— Danbury, Connecticut Notification of Proposed Production Activity; MannKind Corporation, (Fumaryl Diketopiperazone (FDKP) Carrier/ Receptor Powder), Danbury, Connecticut MannKind Corporation (MannKind) submitted a notification of proposed production activity to the FTZ Board for its facility in Danbury, Connecticut within Subzone 76B. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on December 21, 2016. MannKind currently has authority to use the facility for the production of Technosphere Insulin®, an inhalable insulin made by a combination of imported fumaryl diketopiperazone (FDKP) and domestic material active ingredients. MannKind’s current request would add a finished product to the scope of authority. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited to the specific foreign-status materials and components and specific finished products described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. Production under FTZ procedures could exempt MannKind from customs duty payments on the foreign-status components used in export production. On its domestic sales, MannKind would be able to choose the duty rate during customs entry procedures that applies to FDKP carrier/receptor powder (duty rate 6.5%) for the foreign-status components and materials in the existing scope of authority. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is February 15, 2017. A copy of the notification will be available for public inspection at the Office of the Executive Secretary, Foreign-Trade Zones Board, Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230–0002, and in the ‘‘Reading Room’’ section of the Board’s Web site, which is accessible via www.trade.gov/ftz. PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 1689 For further information, contact Juanita H. Chen at Juanita.Chen@ trade.gov or (202) 482–1378. Dated: December 28, 2016. Elizabeth Whiteman, Acting Executive Secretary. [FR Doc. 2016–32034 Filed 1–5–17; 8:45 am] BILLING CODE 3510–DS–P DEPARTMENT OF COMMERCE Bureau of Industry and Security In the Matter of: Dane Francisco Delgado, Inmate Number: 60114–379, Eden, Correctional Institution, P.O. Box 605, Eden, TX 76837; Order Denying Export Privileges On November 4, 2014, in the U.S. District Court for the Southern District of Texas, Dane Francisco Delgado (‘‘Delgado’’), was convicted of violating Section 38 of the Arms Export Control Act (22 U.S.C. 2778 (2012)) (‘‘AECA’’). Specifically, Delgado knowingly and willfully conspired with persons known and unknown to export, furnish, and cause to be exported from the United States to Mexico defense articles designated on the United States Munitions List without having first obtained from the Department of State a license or written authorization for such export. Delgado was sentenced to 60 months in prison, three years of supervised release, and a $100 assessment. Section 766.25 of the Export Administration Regulations (‘‘EAR’’ or ‘‘Regulations’’) 1 provides, in pertinent part, that ‘‘[t]he Director of the Office of Exporter Services, in consultation with the Director of the Office of Export Enforcement, may deny the export privileges of any person who has been convicted of a violation of the Export Administration Act (‘‘EAA’’), the EAR, or any order, license or authorization issued thereunder; any regulation, license, or order issued under the International Emergency Economic Powers Act (50 U.S.C. 1701–1706); 18 U.S.C. 793, 794 or 798; section 4(b) of the Internal Security Act of 1950 (50 1 The Regulations are currently codified in the Code of Federal Regulations at 15 CFR parts 730– 774 (2016). The Regulations issued pursuant to the Export Administration Act (50 U.S.C. 4601–4623 (Supp. III 2015) (available at http:// uscode.house.gov)). Since August 21, 2001, the Act has been in lapse and the President, through Executive Order 13222 of August 17, 2001 (3 CFR, 2001 Comp. 783 (2002)), which has been extended by successive Presidential Notices, the most recent being that of August 4, 2016 (81 FR 52587 (Aug. 8, 2016)), has continued the Regulations in effect under the International Emergency Economic Powers Act (50 U.S.C. 1701, et seq. (2006 & Supp. IV 2010)). E:\FR\FM\06JAN1.SGM 06JAN1

Agencies

[Federal Register Volume 82, Number 4 (Friday, January 6, 2017)]
[Notices]
[Page 1689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-32034]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-085-2016]


Foreign-Trade Zone (FTZ) 76--Danbury, Connecticut Notification of 
Proposed Production Activity; MannKind Corporation, (Fumaryl 
Diketopiperazone (FDKP) Carrier/Receptor Powder), Danbury, Connecticut

    MannKind Corporation (MannKind) submitted a notification of 
proposed production activity to the FTZ Board for its facility in 
Danbury, Connecticut within Subzone 76B. The notification conforming to 
the requirements of the regulations of the FTZ Board (15 CFR 400.22) 
was received on December 21, 2016.
    MannKind currently has authority to use the facility for the 
production of Technosphere Insulin[supreg], an inhalable insulin made 
by a combination of imported fumaryl diketopiperazone (FDKP) and 
domestic material active ingredients. MannKind's current request would 
add a finished product to the scope of authority. Pursuant to 15 CFR 
400.14(b), FTZ activity would be limited to the specific foreign-status 
materials and components and specific finished products described in 
the submitted notification (as described below) and subsequently 
authorized by the FTZ Board.
    Production under FTZ procedures could exempt MannKind from customs 
duty payments on the foreign-status components used in export 
production. On its domestic sales, MannKind would be able to choose the 
duty rate during customs entry procedures that applies to FDKP carrier/
receptor powder (duty rate 6.5%) for the foreign-status components and 
materials in the existing scope of authority. Customs duties also could 
possibly be deferred or reduced on foreign-status production equipment.
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary at the address 
below. The closing period for their receipt is February 15, 2017.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Juanita H. Chen at 
Juanita.Chen@trade.gov or (202) 482-1378.

    Dated: December 28, 2016.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2016-32034 Filed 1-5-17; 8:45 am]
 BILLING CODE 3510-DS-P